Compass Therapeutics, Inc. CMPX Q2 2025 earnings
Reported August 11, 2025 · Before market open
EPS-$0.14Miss by $0.01
EPS estimate-$0.13
Next report
Aug 10, 2026 (In 1 week)Revenue estimate-$600.0K
EPS estimate-$0.10
Versus estimates
Diluted EPS
Ask the moment Compass Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Compass Therapeutics, Inc. report Q2 2025 earnings?
- Compass Therapeutics, Inc. (CMPX) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Compass Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Compass Therapeutics, Inc. reported eps of $-0.14 for Q2 2025.
- Did Compass Therapeutics, Inc. beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.13 by $0.01.
- How did Compass Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 40.0% from $-0.10.
- Where can I find Compass Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001171843-25-005261) directly on SEC EDGAR. The filing index links above go to sec.gov.